Consonance Capital

Consonance Capital Management as of June 30, 2019

Portfolio Holdings for Consonance Capital Management

Consonance Capital Management holds 30 positions in its portfolio as reported in the June 2019 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Amarin Corp Spons Adr New (AMRN) 11.8 $167M 8.6M 19.39
Uniqure Nv SHS (QURE) 10.6 $149M 1.9M 78.15
Iovance Biotherapeutics (IOVA) 10.2 $144M 5.9M 24.52
Pacira Pharmaceuticals (PCRX) 8.6 $122M 2.8M 43.49
Retrophin 5.4 $77M 3.8M 20.09
Catalyst Pharmaceutical Partners (CPRX) 4.9 $69M 18M 3.84
United Therapeutics Corporation (UTHR) 4.3 $60M 771k 78.06
Epizyme 4.2 $60M 4.8M 12.55
Vericel (VCEL) 3.9 $55M 2.9M 18.89
Urogen Pharma (URGN) 3.6 $52M 1.4M 35.94
Vanda Pharmaceuticals (VNDA) 3.6 $51M 3.6M 14.09
Omeros Corporation (OMER) 3.4 $48M 3.1M 15.69
Aerie Pharmaceuticals 3.2 $45M 1.5M 29.55
Insmed Com Par $.01 (INSM) 3.1 $44M 1.7M 25.60
Karyopharm Therapeutics (KPTI) 2.5 $35M 5.8M 5.99
Oxford Immunotec Global Ord Shs 2.3 $32M 2.3M 13.76
Corcept Therapeutics Incorporated (CORT) 2.3 $32M 2.9M 11.15
Intercept Pharmaceuticals In 2.2 $31M 389k 79.57
Aurinia Pharmaceuticals (AUPH) 2.0 $28M 4.2M 6.58
Kadmon Hldgs 1.7 $24M 12M 2.06
Adma Biologics (ADMA) 1.6 $22M 5.7M 3.87
Chemocentryx 1.1 $16M 1.7M 9.30
Staar Surgical Com Par $0.01 (STAA) 1.0 $14M 485k 29.38
Mustang Bio 0.9 $12M 3.4M 3.68
Biosante Pharmaceuticals (ANIP) 0.8 $12M 143k 82.20
Krystal Biotech (KRYS) 0.5 $7.3M 182k 40.27
Savara (SVRA) 0.3 $3.7M 1.6M 2.37
Immunomedics 0.1 $2.0M 145k 13.87
ArQule 0.0 $551k 50k 11.02
Homology Medicines 0.0 $512k 26k 19.57